Percutaneous radiofrequency ablation for hepatocellular carcinoma developed on non-alcoholic fatty liver disease.

Thi Thu Nga NguyenAgnès RodeHervé TrillaudChristophe AubéAnne Frédérique ManichonArnaud HocqueletAnita PaisantThong DaoPierre NahonNathalie Ganne-CarriéLorraine BlaiseFrançois CauchyOlivier SutterOlivier SérorJean Charles Nault

Published in: Liver international : official journal of the International Association for the Study of the Liver (2021)

Percutaneous multibipolar RFA is an efficient treatment in HCC patients with NAFLD or metabolic syndrome and achieved similar long-term oncological outcomes compared to other etiologies.

Keyphrases

radiofrequency ablation
metabolic syndrome
insulin resistance
prostate cancer
radical prostatectomy
type diabetes
cardiovascular disease
combination therapy
uric acid
adipose tissue
cardiovascular risk factors
minimally invasive
liver fibrosis